5-177238273-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_022455.5(NSD1):c.3958C>T(p.Arg1320*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_022455.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Sotos syndrome Pathogenic:4
Variant summary: NSD1 c.3958C>T (p.Arg1320X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 251350 control chromosomes (gnomAD). c.3958C>T has been reported in the literature in individuals affected with Sotos Syndrome, including at least one case where it was confirmed to be de novo (e.g. Nagai_2003, Saugier-Veber_2007, Faundes_2018, Squeo_2020). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
- -
not provided Pathogenic:3
This sequence change creates a premature translational stop signal (p.Arg1320*) in the NSD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NSD1 are known to be pathogenic (PMID: 12464997, 14571271, 15942875, 16247291). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of Sotos syndrome (PMID: 12676901, 29276005). ClinVar contains an entry for this variant (Variation ID: 4143). For these reasons, this variant has been classified as Pathogenic. -
The R1320X nonsense variant in the NSD1 gene has been reported previously in association with Sotos syndrome (Nagai et al., 2003; Tatton-Brown et al., 2005). This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Additionally, the R1320X variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Therefore, the presence of R1320X is consistent with the diagnosis of Sotos syndrome in this individual. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at